The Chemours Company v. DowDupont Inc.

CourtCourt of Chancery of Delaware
DecidedMarch 30, 2020
DocketCA No. 2019-0351-SG
StatusPublished

This text of The Chemours Company v. DowDupont Inc. (The Chemours Company v. DowDupont Inc.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The Chemours Company v. DowDupont Inc., (Del. Ct. App. 2020).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

THE CHEMOURS COMPANY, ) ) Plaintiff, ) ) v. ) C.A. No. 2019-0351-SG ) DOWDUPONT INC., CORTEVA, INC., ) AND E.I. DU PONT DE NEMOURS ) AND COMPANY, ) ) Defendants. )

MEMORANDUM OPINION

Date Submitted: December 18, 2019 Date Decided: March 30, 2020

Joel Friedlander, Jeffrey Gorris, Christopher Foulds, and Christopher P. Quinn, of FRIEDLANDER & GORRIS P.A., Wilmington, Delaware; OF COUNSEL: William Savitt, of WACHTELL, LIPTON, ROSEN & KATZ, New York, New York, Attorneys for Plaintiff The Chemours Company.

Robert S. Saunders, Jennifer C. Voss, Arthur R. Bookout, and Jessica R. Kunz, of SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP, Wilmington, Delaware, Attorneys for Defendants DowDuPont Inc., Corteva, Inc., and E.I. du Pont de Nemours and Company.

GLASSCOCK, Vice Chancellor Shortly after the American Revolution, in 1802, what would become E. I. du

Pont de Nemours and Company (“DuPont”) began construction of its powder mills

on the falls of the Brandywine Creek.1 The enterprise took advantage of the happy

fact that the potential power of the Brandywine was available just a few city blocks

from a deep-water port, in Wilmington. DuPont grew to be a chemical giant. To

point out that DuPont and the family that founded it dominated Delaware’s

economic, civic, and cultural life for most of the State’s existence is to state a truism.

If an example were needed at this time of the inherent frailty and impermanence of

the works of man,2 then one could look to the serial reorganizations that DuPont

found necessary over the past few years. The origins of this litigation are found in

one such, the spin-off from DuPont of its Performance Chemicals unit (the “Spin-

Off”) as The Chemours Company (“Chemours”).

Chemours was created as a wholy-owned subsidiary of DuPont in 2015, then

spun off as an independent entity shortly thereafter. The terms of the Spin-Off were

provided by contract, notably a separation agreement (the “Separation Agreement”).

Among the assets and liabilities assigned to Chemours in the Separation Agreement

were certain historical environmental liabilities, including a duty to indemnify

DuPont for any damage it may incur relating to those liabilities. In this Action,

1 DuPont de Nemours, Inc., Our History, https://www.dupont.com/about/our-history.html. 2 As I write, Delaware’s courthouses are closed to the public due to the COVID-19 virus.

1 Chemours alleges that DuPont vastly and wrongfully underestimated the size of

these historic environmental liabilities, and seeks to limit its indemnification

obligations to, at most, the amount that it purports DuPont certified as Chemours’

maximum pecuniary exposure at the time of the Spin-Off.

This Memorandum Opinion resolves the Defendants’ Motion to Dismiss for

lack of subject matter jurisdiction. DuPont points to a broad provision in the

Separation Agreement referring all disputes arising from the agreement to binding

arbitration. The Separation Agreement provides explicitly that arbitrability is a

question for the arbitrator. Thus, per DuPont, I am without jurisdiction to hear the

matter.

Chemours, for its part, maintains that it did not consent to any terms of the

Separation Agreement, and thus the arbitration provisions are unenforcable,

contractually; alternatively, it argues that the arbitrability provisions are

unconscionable, and thus void. The matter was ably briefed and passionately

argued, with each side maintaining strenuously that public policy requires that the

matter be decided in its favor. Nonetheless, my decision does not rest on those policy

grounds; I find the issues are governed by rather straightforward application of

settled law. I find the language of the Separation Agreement referring arbitrability

to the arbitrator controlling here. Accordingly, I have no jurisdiction to entertain

2 this matter, and the Defendants’ Motion to Dismiss must be granted. My reasoning

is below.

I. BACKGROUND3

A. The Parties and Relevant Non-parties

Plaintiff Chemours is a Delaware corporation headquartered in Delaware.4

Chemours is a manufacturer of performance chemicals with customers in more than

120 countries and nearly 7,000 employees worldwide.5 Pursuant to the Spin-Off,

Chemours was separated from DuPont’s ownership in a transaction whereby

Chemours stock was distributed to DuPont stockholders.6 Since the Spin-Off

Chemours has been an independent, publicly traded company.7

Defendant DuPont is a Delaware corporation headquartered in Delaware.8

DuPont merged with The Dow Chemical Company (“Dow”) in 2017.9 Before its

merger with Dow, DuPont was a publicly traded company that operated businesses

including agriculture, electronics and communications, industrial biosciences,

3 The facts, except where otherwise noted, are drawn from the well-pled allegations of The Chemours Company’s Verified First Amended Complaint, Docket Item (“D.I.”) 33 (the “First Amended Complaint” or “First Am. Compl.”) and exhibits or documents incorporated by reference therein, which are presumed true for purposes of evaluating the Defendants’ Motion to Dismiss. 4 First Am. Compl., ¶ 11. 5 Id. 6 Id. 7 Id. 8 Id. ¶ 12. 9 Id.

3 nutrition and health, performance materials, and protection solutions segments.10

DuPont is now a wholly-owned subsidiary of Defendant Corteva, Inc. (“Corteva”).11

Defendant DuPont de Nemours, Inc. (“DuPont de Nemours”) is a Delaware

corporation headquartered in Delaware.12 DuPont de Nemours was formerly known

as DowDuPont Inc. (“DowDuPont”), and was formed following DuPont’s merger

with Dow.13 Following a series of reorganization transactions in 2019, DuPont de

Nemours became an independent company and retained DowDuPont’s specialty

products business along with the balance of the financial assets and liabilities of

historical DuPont not assumed by Corteva.14

Defendant Corteva is a Delaware corporation headquartered in Delaware.15

Pursuant to the reorganization of DowDuPont, DowDuPont distributed all issued

and outstanding shares of Corteva common stock to DowDuPont’s stockholders by

a pro rata dividend.16 Corteva thereafter became an independent company.17

Corteva contains DowDuPont’s agricultural and nutritional businesses, along with

10 Id. 11 Id. 12 Id. ¶ 13. Somewhat confusingly, DuPont de Nemours refers to itself currently as “DuPont”— however, the DuPont that is the focus of this Memorandum Opinion is the separate predecessor entitiy E. I. du Pont de Nemours and Company, which also referred to itself as DuPont. 13 Id. DowDuPont is the entity name indicated in the case caption. 14 Id. ¶¶ 13, 72. 15 Id. ¶ 14. 16 Id. 17 Id. ¶ 72.

4 all of the outstanding common stock of the historical entity DuPont exclusive of its

subsidiaries.18

Non-party Dow Inc. was the third independent entity (along with DuPont de

Nemours and Corteva) resulting from the reorganization of DowDuPont.19 Dow Inc.

contains DowDuPont’s materials sciences businesses, along with all financial assets

and liabilities of historical Dow not related to its agriculture, specialty products, or

materials sciences businesses.20

B. Events Leading Up to the Spin-Off

In 2013, DuPont’s management began consideration of restructuring

transactions in an initiative entitled “Project Beta.”21 Project Beta focused on

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Perry v. Thomas
482 U.S. 483 (Supreme Court, 1987)
First Options of Chicago, Inc. v. Kaplan
514 U.S. 938 (Supreme Court, 1995)
Doctor's Associates, Inc. v. Casarotto
517 U.S. 681 (Supreme Court, 1996)
Howsam v. Dean Witter Reynolds, Inc.
537 U.S. 79 (Supreme Court, 2002)
Buckeye Check Cashing, Inc. v. Cardegna
546 U.S. 440 (Supreme Court, 2006)
Arthur Andersen LLP v. Carlisle
556 U.S. 624 (Supreme Court, 2009)
Quilloin v. Tenet HealthSystem Philadelphia, Inc.
673 F.3d 221 (Third Circuit, 2012)
Anadarko Petroleum Corp. v. Panhandle Eastern Corp.
545 A.2d 1171 (Supreme Court of Delaware, 1988)
Elf Atochem North America, Inc. v. Jaffari
727 A.2d 286 (Supreme Court of Delaware, 1999)
Harman v. Masoneilan International, Inc.
442 A.2d 487 (Supreme Court of Delaware, 1982)
Trenwick America Litigation Trust v. Billett
931 A.2d 438 (Supreme Court of Delaware, 2007)
Lecates v. Hertrich Pontiac Buick Co.
515 A.2d 163 (Superior Court of Delaware, 1986)
James & Jackson, LLC. v. Willie Gary, LLC.
906 A.2d 76 (Supreme Court of Delaware, 2006)
Trenwick America Litigation Trust v. Ernst & Young, L.L.P.
906 A.2d 168 (Court of Chancery of Delaware, 2006)
AFSCME Locals 1102 & 320 v. City of Wilmington
858 A.2d 962 (Court of Chancery of Delaware, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
The Chemours Company v. DowDupont Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-chemours-company-v-dowdupont-inc-delch-2020.